Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Reexamination Certificate
2005-07-19
2005-07-19
Zucker, Paul A. (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
C562S126000
Reexamination Certificate
active
06919379
ABSTRACT:
Novel compounds of formula (I) wherein R1represents hydrogen; R2represents hydroxy, fluoro, or an oxo group; R3represents hydrogen; R4represents hydrogen; and pharmaceutically acceptable salts, solvates, and the stereoisomers thereof, with the exception of the racemate of (3-amino-2-hydroxypropyl)sulphinic acid. The compounds are useful in therapy, especially for the treatment of reflux disease. The invention is also related to processes for their preparation, intermediates of said process and pharmaceutical compositions containing said therapeutically active compounds and to the use of said active compounds in therapy
REFERENCES:
patent: 4599346 (1986-07-01), Schickaneder et al.
patent: 5036057 (1991-07-01), Martin
patent: 5162364 (1992-11-01), Debaert et al.
patent: 5214063 (1993-05-01), Debaert et al.
patent: 5278166 (1994-01-01), Debaert et al.
patent: 6576626 (2003-06-01), Elebring et al.
patent: 449046 (1967-12-01), None
patent: 0181833 (1986-05-01), None
patent: 0356128 (1990-02-01), None
patent: 0399949 (1990-11-01), None
patent: 2722192 (1996-01-01), None
patent: WO-87/04077 (1987-07-01), None
patent: WO-96/11680 (1996-04-01), None
patent: WO-98/11885 (1998-03-01), None
Wolfgang Froestl et al., “Phosphinic Acid Analogues of GABA. 1. New Potent and Selective GABABAgonists”; J. Med. Chem., 1995, 38, 3297-3312.
Nicholas I. Carruthers et al., “Synthesis of a Series of Sulfinic Acid Analogs of GABA and Evaluation of Their GABABReceptor Affinities”; Bioorg. & Med. Chem. Lett. (1998), 8, 3059-3064.
Richard H. Holloway and John Dent, “Pathophysiology of Gastroesophageal Reflux”; Gastroenterology Clinics of North America, vol. 19, No. 3, Sep. 1990, p. 517-535.
Fitzpatrick Kevin
Geiss William
Lehmann Anders
Sunden Gunnel
Unge Sverker Von
AstraZeneca AB
White & Case LLP
Zucker Paul A.
LandOfFree
Compounds useful in reflux disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds useful in reflux disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful in reflux disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3383105